JP Morgan International Finance Ltd v WEREALIZE.COM Ltd [2024] EWHC 1437 (Comm) (13 June 2024)

JP Morgan International Finance Ltd v WEREALIZE.COM Ltd [2024] EWHC 1437 (Comm) (13 June 2024)

The valuation provisions in Schedule 1 of the SHA require the Call Option Fair Market Value to be determined without regard to the value of Viva to any particular purchaser, on the basis of actual historical financial performance and projected financial performance as provided by Viva under paragraph 3.7(b)(vi), and not limited to the current approved Business Plan. Regulatory restrictions specific to JPM (such as Regulation K) are to be disregarded in the valuation. The contract's language is clear and does not support JPM's construction limiting valuation to the current business or Business Plan.

Citation
[2024] EWHC 1437 (Comm)
Parties
Claimant (cl 2024 000084), Defendant (cl 2024 000086): J. P. Morgan International Finance Limited; Defendant (cl 2024 000084), Claimant (cl 2024 000086): WEREALIZE. COM Limited
Jurisdiction
England and Wales
Judgment Date
13 June 2024
Procedural Posture
Commercial Contractual Dispute (part 7 and Part 8 Claims) / Expedited Trial, Judgment
Outcome
Declaratory relief granted in favour of WRL's construction; JPM's restrictive interpretation rejected.
Legal Topics
Shareholders' Agreements, Valuation Methodology, Declaratory Relief, Contractual Construction, Financial Projections, Regulatory Restrictions
Contract Law Commercial Law Shareholders' Agreements Valuation Methodology Declaratory Relief Contractual Construction Financial Projections Regulatory Restrictions

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 2 Authorities cited 6 Party arguments 2 Amounts and remedies 4
Sign in to unlock

Parties

J. P. Morgan International Finance Limited

Claimant (cl 2024 000084), Defendant (cl 2024 000086)

WEREALIZE. COM Limited

Defendant (cl 2024 000084), Claimant (cl 2024 000086)

Procedural Posture

Commercial Contractual Dispute (part 7 and Part 8 Claims) / Expedited Trial, Judgment

Legal Issues

  1. 1 Proper construction of valuation provisions in Schedule 1 of SHA
  2. 2 Whether valuation must disregard regulatory restrictions (Regulation K)
  3. 3 Whether financial projections must be based on current Business Plan

Ratio Decidendi

The valuation provisions in Schedule 1 of the SHA require the Call Option Fair Market Value to be determined without regard to the value of Viva to any particular purchaser, on the basis of actual historical financial performance and projected financial performance as provided by Viva under paragraph 3.7(b)(vi), and not limited to the current approved Business Plan. Regulatory restrictions specific to JPM (such as Regulation K) are to be disregarded in the valuation. The contract's language is clear and does not support JPM's construction limiting valuation to the current business or Business Plan.

Court Disposition

Declaratory relief granted in favour of WRL's construction; JPM's restrictive interpretation rejected.

Orders

  • Declaration that the Call Option Fair Market Value is to be determined without regard to regulatory restrictions specific to JPM (including Regulation K) and not limited to the current approved Business Plan.
  • Valuation Experts are to base their assessment on actual historical and projected financial performance as provided by Viva under paragraph 3.7(b)(vi) of Schedule 1 of the SHA.